6 research outputs found
The intercultural dodo: a drawing from the School of Bundi, Rājasthān
The iconic dodo Raphus cucullatus once occurred on the isolated Mascarene Island of Mauritius, situated in the southwestern Indian Ocean. Mauritius was once a paradise for a unique flora and fauna that evolved in isolation for 8 million years. The dodo was sought after by seafarers who visited the island from the early sixteenth century onwards because we know from remains surviving in collections and a series of artworks that captive dodos were transported to Europe, India and Japan. This article presents a hitherto unpublished image of a dodo, preserved in the collection of the Trustees, Chhatrapati Shivaji Maharaj Vastu Sangrahalaya, Mumbai, the formerly Prince of Wales Museum of Western India. The bird is situated in a non-Mauritian environment together with other animals and it is named in Hindi. We further explore the background of this creation and its implication on the iconography of the dodo
Co-Treatment with a Novel Heat Shock Protein (hsp) 90 Inhibitor IPI504 and the Histone Deacetylase Inhibitor (HDI) Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA): A Highly Active Combination Against Wild Type or Mutant Bcr-Abl-T315I or FLT-3-ITD-Containing Human Leukemia Cells.
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
International audienceBackground: A better understanding of the molecular profile of anal squamous cell carcinomas (ASCCs) is necessary to consider new therapeutic approaches, and the identification of prognostic and predictive factors for response to treatment. Methods: We retrospectively analysed tumours from ASCC patients for mutational analysis of KRAS, NRAS, HRAS, BRAF, PIK3CA, MET, TP53 and FBXW7 genes by HRM and Sanger sequencing analysis. Results: Specimens from 148 patients were analysed: 96 treatment-naive tumours and 52 recurrences after initial radiotherapy (RT) or chemoradiotherapy (CRT). Mutations of KRAS, PIK3CA, FBXW7 and TP53 genes were present in 3 (2.0%), 30 (20.3%), 9 (6.1%) and 7 tumours (4.7%), respectively. The distribution of the mutations was similar between treatment-naive tumours and recurrences, except for TP53 mutations being more frequent in recurrences (P = 0.0005). In patients treated with abdominoperineal resection (APR) after relapse (n = 38, median follow-up of 18.2 years), overall survival (OS) was significantly correlated with HPV16 status (P = 0.048), gender (P = 0.045) and PIK3CA mutation (P = 0.037). The PIK3CA status retained its prognostic significance in Cox multivariate regression analysis (P = 0.025). Conclusions: Our study identified PIK3CA mutation as an independent prognostic factor in patients who underwent APR for ASCC recurrence, suggesting a potential benefit from adjuvant treatment and the evaluation of targeted therapies with PI3K/Akt/mTor inhibitors in PIK3CA-mutated patients